Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28776 - 28800 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cytarabine	Approved Investigational	UBE2C	11065	downregulated	Cytarabine results in decreased expression of UBE2C mRNA	20q13.12	A20666
Cytarabine	Approved Investigational	UBL3	5412	upregulated	Cytarabine results in increased expression of UBL3 mRNA	13q12.3	A20985
Cytarabine	Approved Investigational	USP7	7874	downregulated	Cytarabine results in decreased expression of USP7 mRNA	16p13.2	A20985
Cytarabine	Approved Investigational	VASN	114990	downregulated	Cytarabine results in decreased expression of VASN mRNA	16p13.3	A21886
Cytarabine	Approved Investigational	VCAM1	7412	upregulated	Cytarabine results in increased expression of VCAM1 mRNA	1p21.2	A21886
Cytarabine	Approved Investigational	VEZF1	7716	upregulated	Cytarabine results in increased expression of VEZF1 mRNA	17q22	A20985
Cytarabine	Approved Investigational	VGLL4	9686	downregulated	Cytarabine results in decreased expression of VGLL4 mRNA	3p25.3-p25.2	A21886
Cytarabine	Approved Investigational	VRK2	7444	downregulated	Cytarabine results in decreased expression of VRK2 mRNA	2p16.1	A21886
Cytarabine	Approved Investigational	WFDC3	140686	downregulated	Cytarabine results in decreased expression of WFDC3 mRNA	20q13.12	A21886
Cytarabine	Approved Investigational	WIPF1	7456	downregulated	Cytarabine results in decreased expression of WIPF1 mRNA	2q31.1	A21886
Cytarabine	Approved Investigational	XRCC1	7515	upregulated	Cytarabine results in increased expression of XRCC1 mRNA	19q13.2	A20985
Cytarabine	Approved Investigational	YIF1A	10897	downregulated	Cytarabine results in decreased expression of YIF1A mRNA	11q13.2	A21886
Cytarabine	Approved Investigational	ZC3HAV1	56829	downregulated	Cytarabine results in decreased expression of ZC3HAV1 mRNA	7q34	A21886
Cytarabine	Approved Investigational	ZFHX4	79776	upregulated	Cytarabine results in increased expression of ZFHX4 mRNA	8q21.13	A21886
Cytarabine	Approved Investigational	ZFPM2	23414	downregulated	Cytarabine results in decreased expression of ZFPM2 mRNA	8q23	A21886
Cytarabine	Approved Investigational	ZNF423	23090	upregulated	Cytarabine results in increased expression of ZNF423 mRNA	16q12.1	A21886
Cytarabine	Approved Investigational	ZNF467	168544	downregulated	Cytarabine results in decreased expression of ZNF467 mRNA	7q36.1	A21886
Cytarabine	Approved Investigational	ZNF702P	79986	downregulated	Cytarabine results in decreased expression of ZNF702P mRNA	19q13.41	A21886
Cytarabine	Approved Investigational	ZNRF2P1	441208	downregulated	Cytarabine results in decreased expression of ZNRF2P1 mRNA	7p14.3	A21886
Cytarabine	Approved Investigational	ZSCAN31	64288	upregulated	Cytarabine results in increased expression of ZSCAN31 mRNA	6p22.1	A20985
Dacarbazine	Approved Investigational	CXCL8	3576	upregulated	Dacarbazine results in increased expression of CXCL8 mRNA	4q13.3	A21889 A21890 A21891
Dacarbazine	Approved Investigational	IRF1	3659	upregulated	Dacarbazine results in increased expression of IRF1 mRNA	5q31.1	A21892
Dacarbazine	Approved Investigational	VEGFA	7422	upregulated	Dacarbazine results in increased expression of VEGFA mRNA	6p21.1	A21889 A21890 A21891
Dactinomycin	Approved Investigational	ABHD3	171586	upregulated	Dactinomycin results in increased expression of ABHD3 mRNA	18q11.2	A21863
Dactinomycin	Approved Investigational	ARHGDIB	397	upregulated	Dactinomycin results in increased expression of ARHGDIB mRNA	12p12.3	A21863

Displaying entries 28776 - 28800 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability